Ebola becomes latest stock scam, U.S. SEC says
20/11/2014 15:46
By Sarah N. Lynch
WASHINGTON, Nov 20 (Reuters) - U.S. regulators on Thursday
suspended trading in four small over-the-counter stocks of
companies that they said have been touting the development of
products to prevent or treat the Ebola virus, and warned
investors to beware of similar scams.
The Securities and Exchange Commission said it had suspended
trading in the shares of New York-based Bravo Enterprises Ltd,
California-based Immunotech Laboratories Inc IMMB.PK ,
Canada-based Myriad Interactive Media Inc MYRYE.OB and
Wholehealth Products Inc GWPC.PK , which is also located in
California.
The SEC also issued an alert, warning that "con artists" may
be soliciting investors and claiming to be developing treatment
or other medicine to prevent the deadly virus.
(Reporting by Sarah N. Lynch; Editing by Bill Trott)
((sarah.n.lynch@thomsonreuters.com; 202-354-5831;))
Keywords: SEC EBOLA/SCAMS